ATE321558T1 - Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen - Google Patents

Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen

Info

Publication number: ATE321558T1
Authority: AT; Austria
Prior art keywords: progesterone; ischemia; reduction; treatment; women receiving
Prior art date: 1996-11-04

Application number

AT97946681T

Other languages

English (en)

Inventor

Howard L Levine

William J Bologna

Original Assignee

Columbia Lab Bermuda Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-04

Filing date

1997-11-04

Publication date

2006-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE321558(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-04 Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE321558T1 publication Critical patent/ATE321558T1/de

Links

RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title 2
229940011871 estrogen Drugs 0.000 title 1
239000000262 estrogen Substances 0.000 title 1
208000028867 ischemia Diseases 0.000 title 1
230000009245 menopause Effects 0.000 title 1
229960003387 progesterone Drugs 0.000 title 1
239000000186 progesterone Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Vascular Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT97946681T 1996-11-04 1997-11-04 Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen ATE321558T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/743,153 US5985861A (en)	1996-11-04	1996-11-04	Progesterone for treating or reducing ischemia

Publications (1)

Publication Number	Publication Date
ATE321558T1 true ATE321558T1 (de)	2006-04-15

Family

ID=24987712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97946681T ATE321558T1 (de)	1996-11-04	1997-11-04	Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen

Country Status (26)

Country	Link
US (2)	US5985861A (de)
EP (1)	EP0956023B1 (de)
KR (1)	KR100434623B1 (de)
CN (1)	CN100341512C (de)
AR (1)	AR009407A1 (de)
AT (1)	ATE321558T1 (de)
AU (1)	AU715740C (de)
BR (1)	BR9710918A (de)
CA (1)	CA2270565C (de)
DE (1)	DE69735598T2 (de)
DK (1)	DK0956023T3 (de)
ES (1)	ES2262196T3 (de)
GE (1)	GEP20022630B (de)
HU (1)	HUP9904045A3 (de)
IL (1)	IL127455A (de)
LV (1)	LV12342B (de)
MA (1)	MA24391A1 (de)
MY (1)	MY121627A (de)
NO (1)	NO324278B1 (de)
NZ (1)	NZ335306A (de)
PE (1)	PE9899A1 (de)
PT (1)	PT956023E (de)
RO (1)	RO120607B1 (de)
UA (1)	UA66772C2 (de)
WO (1)	WO1998019681A1 (de)
ZA (1)	ZA979862B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6056972A (en) *	1997-02-26	2000-05-02	Dimera, Llc	Method for reducing coronary artery reactivity
US6602487B1 (en)	1997-02-26	2003-08-05	Dimera Incorporated	Methods and tests for producing and for inhibiting coronary artery vasospasms
US20040234606A1 (en) *	1997-09-12	2004-11-25	Levine Howard L.	Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de)	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
GB0107383D0 (en) *	2001-03-23	2001-05-16	Univ Edinburgh	Lipid profile modulation
US20080182841A1 (en) *	2001-10-29	2008-07-31	Levine Howard L	Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) *	2001-10-29	2003-06-19	Levine Howard L.	Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en)	2001-10-29	2013-04-23	Columbia Laboratories, Inc.	Extended, controlled-release pharmaceutical compositions using charged polymers
US7572780B2 (en)	2003-01-21	2009-08-11	Dimera, Incorporated	Method and kit for reducing the symptoms of peripheral vascular disease
AU2004233997C1 (en) *	2003-04-29	2014-01-30	Massachusetts Institiute Of Technology	Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) *	2005-06-10	2020-03-19	Continental Automotive Gmbh	Scheibenwaschvorrichtung
US8828981B2 (en)	2007-02-06	2014-09-09	George Creasy	Progesterone for the treatment or prevention of spontaneous preterm birth
EP2359807B1 (de)	2008-02-04	2017-07-26	Ferring B.V.	Monolithische intravaginale ringe mit progesteron und verfahren zu ihrer herstellung und verwendung
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt)	2011-11-23	2021-12-14	Therapeuticsmd, Inc	Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru)	2014-05-22	2018-06-26	Терапьютиксмд, Инк.	Натуральные комбинированные гормонозаместительные составы и терапии
RU2016141135A (ru)	2014-07-29	2018-08-28	Терапьютиксмд, Инк.	Трансдермальный крем
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
JP2021535183A (ja) *	2018-09-07	2021-12-16	トラスティーズ・オヴ・ダートマス・カレッジ	Ｃ１９骨格およびステロイドならびにそれらの使用および製造方法
US11512107B2 (en)	2018-09-07	2022-11-29	Trustees Of Dartmouth College	Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations
GB202316026D0 (en) *	2023-10-19	2023-12-06	Theramex Hq Uk Ltd	Methods of prevention or treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU1124906A1 (ru) *	1982-05-25	1984-11-23	Ивановский государственный медицинский институт им.А.С.Бубнова	Способ коррекции ишемических повреждений консервированной донорской почки
AU565354B2 (en) *	1983-11-14	1987-09-10	Bio-Mimetics Inc.	Bioadhesive compositions and methods of treatment therewith
US5543150A (en) *	1993-09-15	1996-08-06	Columbia Laboratories, Inc.	Method of progesterone delivery and affect thereof

1996
- 1996-11-04 US US08/743,153 patent/US5985861A/en not_active Expired - Lifetime
1997
- 1997-11-03 ZA ZA9709862A patent/ZA979862B/xx unknown
- 1997-11-03 MA MA24853A patent/MA24391A1/fr unknown
- 1997-11-04 BR BR9710918-5A patent/BR9710918A/pt not_active Application Discontinuation
- 1997-11-04 MY MYPI97005220A patent/MY121627A/en unknown
- 1997-11-04 ES ES97946681T patent/ES2262196T3/es not_active Expired - Lifetime
- 1997-11-04 WO PCT/US1997/020923 patent/WO1998019681A1/en not_active Ceased
- 1997-11-04 EP EP97946681A patent/EP0956023B1/de not_active Expired - Lifetime
- 1997-11-04 KR KR10-1999-7003965A patent/KR100434623B1/ko not_active Expired - Fee Related
- 1997-11-04 PT PT97946681T patent/PT956023E/pt unknown
- 1997-11-04 AR ARP970105144A patent/AR009407A1/es unknown
- 1997-11-04 CA CA002270565A patent/CA2270565C/en not_active Expired - Fee Related
- 1997-11-04 UA UA99052985A patent/UA66772C2/uk unknown
- 1997-11-04 DE DE69735598T patent/DE69735598T2/de not_active Expired - Fee Related
- 1997-11-04 PE PE1997000985A patent/PE9899A1/es not_active Application Discontinuation
- 1997-11-04 NZ NZ335306A patent/NZ335306A/xx not_active IP Right Cessation
- 1997-11-04 GE GEAP19974830A patent/GEP20022630B/en unknown
- 1997-11-04 CN CNB971994145A patent/CN100341512C/zh not_active Expired - Fee Related
- 1997-11-04 AT AT97946681T patent/ATE321558T1/de not_active IP Right Cessation
- 1997-11-04 DK DK97946681T patent/DK0956023T3/da active
- 1997-11-04 AU AU51801/98A patent/AU715740C/en not_active Ceased
- 1997-11-04 RO RO99-00508A patent/RO120607B1/ro unknown
- 1997-11-04 HU HU9904045A patent/HUP9904045A3/hu unknown
1998
- 1998-12-09 IL IL12745598A patent/IL127455A/xx not_active IP Right Cessation
1999
- 1999-02-01 US US09/240,610 patent/US6054447A/en not_active Expired - Lifetime
- 1999-05-03 NO NO19992140A patent/NO324278B1/no unknown
- 1999-05-28 LV LVP-99-88A patent/LV12342B/en unknown

Also Published As

Publication number	Publication date
CA2270565C (en)	2007-02-20
US6054447A (en)	2000-04-25
DK0956023T3 (da)	2006-08-07
AU5180198A (en)	1998-05-29
PE9899A1 (es)	1999-02-08
NO992140D0 (no)	1999-05-03
ES2262196T3 (es)	2006-11-16
KR20000053056A (ko)	2000-08-25
UA66772C2 (uk)	2004-06-15
AU715740B2 (en)	2000-02-10
PT956023E (pt)	2006-08-31
CA2270565A1 (en)	1998-05-14
HK1020534A1 (en)	2000-05-12
IL127455A0 (en)	1999-10-28
MA24391A1 (fr)	1998-07-01
NO992140L (no)	1999-05-04
EP0956023A1 (de)	1999-11-17
AR009407A1 (es)	2000-04-12
RO120607B1 (ro)	2006-05-30
MY121627A (en)	2006-02-28
BR9710918A (pt)	2000-01-11
DE69735598D1 (de)	2006-05-18
CN1235549A (zh)	1999-11-17
WO1998019681A1 (en)	1998-05-14
HUP9904045A2 (hu)	2000-04-28
HUP9904045A3 (en)	2000-11-28
CN100341512C (zh)	2007-10-10
NO324278B1 (no)	2007-09-17
KR100434623B1 (ko)	2004-06-05
NZ335306A (en)	2000-12-22
AU715740C (en)	2004-04-29
EP0956023B1 (de)	2006-03-29
ZA979862B (en)	1998-05-25
LV12342A (lv)	1999-09-20
LV12342B (en)	2000-01-20
GEP20022630B (en)	2002-02-25
US5985861A (en)	1999-11-16
IL127455A (en)	2005-03-20
DE69735598T2 (de)	2006-12-28

Legal Events

Date

Code

Title

Description

2006-12-15

UEP

Publication of translation of european patent specification

Ref document number: 0956023

Country of ref document: EP

2009-08-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE321558T1 (de)	2006-04-15	Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen
FR2754713B1 (fr)	1999-01-08	Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
ATE279916T1 (de)	2004-11-15	Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden
DE59711148D1 (de)	2004-01-29	Vorrichtung für die behandlung von körpersubstanzen
DE69927823D1 (de)	2006-03-02	Hydrogel für die therapeutische behandlung von aneurysmas
DE69939058D1 (de)	2008-08-21	Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69718731D1 (de)	2003-03-06	Kombinationstherapie für die Behandlung von Psychosen
MY113079A (en)	2001-11-30	Estrogen agonists as remedies for cardiovascular diseases
AU2277501A (en)	2001-07-09	One-step system for cleansing, conditioning, and treating the skin
DE69725484D1 (de)	2003-11-20	Vorrichtung zur Behandlung von Harninkontinenz
DE69524682D1 (de)	2002-01-31	Mittel zur Behandlung von Wunden
ATE329911T1 (de)	2006-07-15	Fsh mimetika zur behandlung von infertilität
ZA977513B (en)	1998-02-19	Skin tanning compositions and method.
DE3782214D1 (de)	1992-11-19	Mittel zur behandlung des scheidenmilieus.
ATE332705T1 (de)	2006-08-15	Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen
MA24332A1 (fr)	1998-04-01	Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau
ATA184995A (de)	1996-10-15	Vorrichtung zur entwässerung von feststoff-flüssigkeitssuspensionen, insbesondere zellstoffsuspensionen
ATE347372T1 (de)	2006-12-15	Vakzine zur behandlung von mycosen
ATE222910T1 (de)	2002-09-15	Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE59801385D1 (de)	2001-10-11	Durchlaufanlage für die behandlung von werkstücken
DE69900034D1 (de)	2001-01-04	System für die Behandlung von Dung
GB9916729D0 (en)	1999-09-15	Fuller for the treatment of leather,pelts and the like
DE3777656D1 (de)	1992-04-23	Mittel zur behandlung von alopezien.
DE59002772D1 (de)	1993-10-28	Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms.
ATE237354T1 (de)	2003-05-15	Anti-enzym antikörper enthaltende zusammensetzungen für die behandlung der haut